Akari Therapeutics PLC expected to post a loss of 6 cents a share - Earnings Preview

Akari Therapeutics

14/07/2023 11:25

* Akari Therapeutics PLC  AKTX.OQ   AKTX.O  is expected
to report
results on July 14 (estimated).
    * 
    * ​Refinitiv's mean analyst estimate for Akari Therapeutics
PLC is
for a loss of 6 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Akari
Therapeutics PLC is $2.75​, above​ its last closing price
of $0.18. ​​​

This summary was machine generated July 14 at 10:25 GMT.  All
figures in US dollars  unless otherwise stated